Form 4: SEALSQ Corp: Insider Trades Under 10b5-1 Plan

SEALSQ Corp officer Jean-Pierre Enguent reports transactions involving ordinary shares and stock options under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Jean-Pierre Enguent, Vice President of R&D at SEALSQ Corp, has reported transactions related to the company's ordinary shares and employee stock options.
• These transactions were executed under a Rule 10b5-1 trading plan, adopted on October 13, 2025, which is designed to comply with affirmative defense conditions for insider trading.
• On June 1, 2026, 15,000 ordinary shares were acquired at a price of $0.01 per share.
• On June 3, 2026, 15,000 ordinary shares were disposed of at a weighted average price of $3.5101, with individual sales ranging from $3.44 to $3.66.
• Additionally, 60,000 employee stock options were acquired on June 1, 2026, with an exercise price of $0.01.
• A further 15,000 employee stock options were disposed of on June 1, 2026, also under the 10b5-1 plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While it details significant stock option exercises and share disposals, these actions were conducted under a pre-established Rule 10b5-1 plan, mitigating concerns about opportunistic insider trading.

Positives

• The transactions were conducted under a Rule 10b5-1 trading plan, indicating a pre-determined and structured approach to insider trading, which can provide a degree of transparency and compliance.
• The acquisition of ordinary shares at a nominal price of $0.01 suggests a potential benefit or grant to the reporting person.
• The exercise of stock options at a low price ($0.01) could indicate a favorable position for the reporting person if the market price of the shares is significantly higher.

Negatives

• The disposal of 15,000 ordinary shares at a weighted average price of $3.5101 represents a significant sale by a key executive.
• The reporting person's beneficial ownership of ordinary shares decreased by 15,000 following the reported sale.

Risks

• While the transactions are under a 10b5-1 plan, significant sales by a high-ranking executive could be interpreted negatively by the market, potentially impacting share price.
• The specific details of the Rule 10b5-1 plan, such as the duration and the triggers for sales, are not fully disclosed in this filing, which could obscure potential future selling pressure.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions executed under a pre-defined trading plan.

Management Comments

• The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.
• The options exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.

Industry Context

StockSavvy.ai notes that the use of Rule 10b5-1 plans is a common and accepted practice for corporate insiders to manage their stock transactions in a way that avoids accusations of insider trading. This filing indicates SEALSQ Corp's executive is adhering to such compliance measures.

Stakeholder Impact

• Shareholders: May observe the sale of shares by an executive, which could be interpreted in various ways, though the 10b5-1 plan provides a layer of reassurance regarding compliance.
• Employees: The exercise of stock options by management can be seen as a positive sign of confidence in the company's future, but the sale of shares might temper this perception.
• Management: The reporting person is managing their personal equity holdings in a structured and compliant manner.

Next Steps

• Continued adherence to the Rule 10b5-1 trading plan for future transactions.
• Potential for further disclosures as transactions under the plan are executed.

Key Dates

Keywords

SEALSQ Corp, Form 4, Insider Trading, Rule 10b5-1, Stock Options, Ordinary Shares, Jean-Pierre Enguent, Beneficial Ownership, SEC Filing, LAES